Haloperidol decanoate impurity mixture

Hazard statements (CLP)

H302, H361d

Code

Statements

H302

Harmful if swallowed

SECTION 2: Hazards identification

Adverse physicochemical, human health and environmental effects

Expert judgement and weight of evidence determination.

2.2 Label elements

Labelling

Hazard pictograms

GHS07 GHS08 GHS08

Signal word

Warning

Contains

Haloperidol undecanoate; Haloperidol octanoate; Haloperidol dodecanoate

Hazard statements

H302 - Harmful if swallowed. H361d - Suspected of damaging the unborn child.

Precautionary statements

P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P264 - Wash hands, forearms and face thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P301+P312 - IF SWALLOWED: Call a POISON CENTRE or doctor if you feel unwell. P308+P313 - IF exposed or concerned: Get medical advice/attention. P330 - Rinse mouth. P405 - Store locked up. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation. Labelling according to: exemption for inner packaging where the contents do not exceed 10ml

Hazardous Ingredients

Haloperidol undecanoate; Haloperidol octanoate; Haloperidol dodecanoate

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %